Navigation Links
ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
Date:12/4/2008

Celebrity duo bring sports flavor to the conversation about a serious men's health threat

Cary, N.C. (PRWEB) December 4, 2008 -- College basketball analyst and sports ambassador Dick Vitale and co-host of ESPN's Pardon the Interruption Michael Wilbon have teamed up with ESPN, The V Foundation for Cancer Research® and Stand Up To Cancer™ in an effort to create a national discussion about the often ignored reality of prostate cancer and to help men start to understand their potential risk for the disease. Prostate cancer is among the biggest men's health concerns. It currently affects approximately two million American men; more than 186,000 men will be diagnosed with prostate cancer in 2008 alone.

The effort launches with Life: Interrupted - Stand Up To Prostate Cancer, a town hall-style program taking place Thursday, December 4, at New York City's ESPNZone. The event will tackle prostate cancer, which affects 1 out of every 6 American men. This event signals the start of a robust collective fight to defeat prostate cancer by empowering men to take control of their prostate health.

"Last year, I had a prostate health scare. Luckily, I escaped a diagnosis of prostate cancer, but I've since realized I need to take control of my health, especially my prostate health," explained Vitale. "I've joined this cause because I want men to seize control of their health and take the necessary steps to help manage their prostate cancer risk. The disease causes so much of an interruption to a man's life, and the time has come to step up the fight against it."

Vitale and Wilbon are hosting the town hall, which will follow a sports show style format and will feature various sports and prostate cancer-relevant topics. This format engages men about their health within a dialogue of sports topics. Other panelists include one the nation's leading urologist
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. ESPNs Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
2. Triathlete Michael Hennessey Completes 15th Ironman Competition
3. Texas Super Dentist Awards Announced--Dr. Michael McCarty From Austin Smiles Is Awarded For The Third Year In A Row
4. BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
5. Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
6. Vocollect Healthcare Systems Names Michael French as Vice President of Customer Experience
7. UCSF Chancellor J. Michael Bishop Announces Plan To Step Down
8. Majesco Entertainment and Interactive Game Group Announce Jillian Michaels Fitness Ultimatum 2009 Ships to Stores October 21st
9. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
10. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
11. Michael J. Fox Foundation Awards One Million Dollars for Development of Trojan Horse Delivery Technology to Treat Parkinsons Disease

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
(Date:11/30/2009)...and dessert at the holiday table are even less of ...According to a new research report recently appear...ebj.org ), a diet that is high in fat and in sugar...our bodies to store too much fat. This means these... difficult task of converting high-fat and high-su...
(Date:11/30/2009)...J. Rappa, MD, explores the intricate connection be...Healing Heart to Soul: One Doctor’s Journey ...09). , Dallas, TX (Vocus)...o let go of negative emotions, whether caused by u...houlders. Oftentimes, this disease of the human sp...
(Date:11/30/2009)...ov. 30 EMD Serono, an affiliate of...hat it received a refuse to file letter from the U...ug Application (NDA) for Cladribine Tablets, EMD S...on of cladribine, as a therapy for relapsing forms...ill work closely with the FDA to fully understand ...
(Date:11/30/2009)...y help delay progression and reduce expenses, rese...ay News) -- Medical care for osteoarthritis patien...r, according to a new study. , Of that amount, ....1 billion in out-of-pocket costs. Annual insurer ... male patient. Women also have higher out-of-pocke...
(Date:11/30/2009)...ting a tumor without disturbing normal tissue pres...apies can be invasive and harsh. , Researchers a...y they might deliver the right therapy directly to...which specifically bind to living tumor tissue. ,...nt with liver cancer until they found the best mol...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ORTLAND, Ore. New research at Oregon Health & Sci...te suggests vaccines that specifically target HIV ...omes a rapidly replicating, system-wide infection ...icine and will appear in a future printed edition...
...This release is available in French . , Montrea...icts at medically supervised clinics does not pose... a new study by Serge Brochu, a researcher at the ...ation Initiative, didn,t have a negative impact on...
...Past behavior is generally considered to be a good...dicates that may not be the case in the developmen...ls., University of Washington social scientists ... early adolescence. Surprisingly, early signs of ...
...DIANAPOLIS, Feb. 17 The State Commander of the In...t he called a "slap in the face" to supporters of ...y Governor Mitch Daniels. , , "At his (Governor D... and what do we get in return? The same lame, ill-...
...h study of tibolone, also used for osteoporosis bu...increased risk, , , TUESDAY, Feb. 17 (Heal...sed to treat menopausal symptoms and to prevent os...ivors of the disease. , Tibolone isn,t available i...
...sidents at risk for chronic kidney disease urged t...ney disease (CKD), which affects 20 million people....S. and it is growing at a steady and alarming rat...ns or symptoms until the kidneys are about to fail...
Other Medicine News:Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:Medical prescription of heroin does not pose neighborhood risk 2Health News:Anti-social behavior in girls predicts adolescent depression seven years later 2Health News:Legion Condemns Governor's Non-Response to ISSCH Proposal As 'Slap In The Face' 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Task Force Alerting Nevadans to 'Silent' Killer Disease Crisis 2
(Date:11/30/2009)...N.J. and CHICAGO, Nov. 30 Today at...f the Radiological Society of North America (RSN...d the enrollment of the first patient in an intern...fficacy and safety of florbetaben (BAY 94-9172) PE... in the brain, which are a pathological hallmark o...
(Date:11/30/2009)...TEL AVIV, Israel, November 30 Opto...III(TM) dual channel microphone, the most advanced...l magnetic resonance imaging,(fMRI) environments. ... major step forward for fiber,optic microphone tec...r, with,low-latency adaptive noise cancelling. The...
(Date:11/30/2009)... INDIANAPOLIS, Nov. 30 T...roved Cymbalta® (duloxetine HCl) for the main...(GAD) in adults, Eli Lilly and Company (NYSE: LL...ety disorder can be a chronic illness, it is impor...ent option that is effective in both the acute and...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 1NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 2NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3
...Potential of NeoVista,s Epi...9 NeoVista, Inc. made public,yesterday 18-month d...examining its novel epiretinal brachytherapy for t...generation (AMD) at the 41st Scientific Meeting of...tudy, which was initiated,to test the safety and e...
...icals,Inc. (Nasdaq: IDEV ) today announced that i...zation agreement with Teva Pharmaceutical Industri...oclone. Indevus previously,announced promising dat...d,multi-center Phase II trial in patients with per...duced a statistically significant benefit in,multi...
Other Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
Hardy Micro Dissector
Hardy Nasal Bivalve Specula
Landolt Hypophysectomie Instrument, Spoon
Hardy Pituitary Spoons
Medicine Products: